Form D — CNS Pharmaceuticals, Inc.
0001683168-26-004126 · filed 2026-05-19
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $22,525,000
- Total sold
- $22,525,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CNS Pharmaceuticals, Inc.
- CIK
- 1729427
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 2100 WEST LOOP SOUTH
HOUSTON, TX 77027 - Phone
- 800-946-9185
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rami Levin · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Steve O'Loughlin · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Faith Charles · DirectorHouston, TX Find on LinkedIn ↗
-
Michal Fisher · DirectorHouston, TX Find on LinkedIn ↗
-
Jeffry Keyes · DirectorHouston, TX Find on LinkedIn ↗
-
Bettina Cockroft · DirectorHouston, TX Find on LinkedIn ↗
-
Amy Mahery · DirectorHouston, TX Find on LinkedIn ↗
View original on SEC EDGAR.